Askew B. M. (1962) Hyperpyrexia as a contributory factor in the toxicity of amphetamine to aggregated mice.Br. J. Pharmacol. 19, 245–257.
Badiani A., Simona C., and Puglisi-Allegra S. (1992) Chronic stress induces strain-dependent sensitization to the behavioral effects of amphetamine in the mouse.Pharmacol. Biochem. Behav. 43, 53–60.
Battaglia G., Yeh S. Y., O’Hearn E., Molliver M. E., Kuhar M. J., and de Souza E. B. (1987) 3,4-Methylenedioxymethamphetamine and 3,4-methylendioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement [3H]paroxetine-labeled serotonin uptake sites.J. Pharmacol. Exp. Ther. 242, 911–916.
Becker J. B., Robinson T. E., and Lorenz D. A. (1982) Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior.Eur. J. Pharmacol. 80, 65–72.
Boehme R. E. and Ciaranello R. D. (1982) Genetic control of dopamine and serotonin receptors in brain regions in inbred mice.Brain Res. 266, 51–65.
Bowyer J. F., Tank A. W., Newport G. D., Slikker W. Jr., Ali S. F., and Holson R. R. (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.J. Pharmacol. Exp. Ther. 260, 817–824.
Bowyer J. F., Davies D. L., Schmued L., Broening H. W., Newport G. D., Slikker W. Jr., and Holson R. R. (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity.J. Pharmacol. Exp. Ther. 268, 1571–1580.
Bushnell P. J. (1986) Differential effects of amphetamine and related compounds on locomotor activity and metabolic rate in mice.Pharmacol. Biochem. Behav. 25, 161–170.
Busto R. W., Dietrich W. D., Globus M. Y.-T., and Ginsberg M. D. (1989) The importance of brain temperature in cerebral ischemic injury.Stroke 20, 1113,1114.
Chance M. R. A. (1946) Aggregation as a factor influencing the toxicity of sympathomimetic amines in mice.J. Pharmacol. Exp. Ther. 87, 214–219.
Commins D. L., Vosmer G., Virus R. M., Woolverton W. L., Schuster C. R., and Seiden L. A. (1987) Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.J. Pharmacol. Exp. Ther. 241, 338–345.
Fay T. (1959) Early experiences with local and generalized refrigeration of human brain.J. Neurosurg. 16, 239–246.
Fuller R. W. (1978) Neurochemical effects of serotonin neurotoxins: an introduction, inSerotonin Neurotoxins (Jacoby J. H. and Lytle L. D., eds.), New York Academy of Science, New York, pp. 178–181.
Gold L. H., Koob G. F., and Geyer M. A. (1988) Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and n-ethyl-3,4-methylenedioxyamphetamine in rats.J. Pharmacol. Exp. Ther. 247, 547–555.
Gordon C. J., Watkinson W. P., O’Callaghan J. P., and Miller D. B. (1991) Effects of 3,4-methyene-dioxymethamphetamine on autonomic thermoregulatory responses of the the rat.Pharmacol. Biochem. Behav. 38, 339–344.
Heikkila R. E., Hess A., and Duvoisin R. C. (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.Science 224, 1451–1453.
Herman J.-P., Stinus M., and Le Moal M. (1984) Repeated stress increases locomotor response to amphetamine.Psychopharmacology 84, 431–435.
Hohn R. and Lasagna L. (1960) Effects of aggregation and temperature on amphetamine toxicity in mice.Psychopharmacologia 1, 210–220.
Kleven M. S. and Seiden L. S. (1989) D-, L-, and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain.Brain Res. 505, 351–353.
Lee C.-M., Javitch J. A., and Snyder S. H. (1983) Recognition sites for norepinephrine uptake: regulation by neurotransmitter.Science 220, 626–629.
Lesch K. P., Aulakh C. S., Wolozin B. L., Tolliver T. J., Hill J. L., and Murphy D. L. (1993) Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants.Mol. Brain Res. 17, 31–35.
Logan B. J., Laverty L., Sanderson W. D., and Yee Y. B. (1988) Differences between rats and mice in MDMA (methylenedioxymethamphetamine) neurotoxicity.Eur. J. Pharmacol. 152, 227–234.
Miller D. B. and O’Callaghan J. P. (1993) The interactions of MK-801 with the amphetamine analogues d-methamphetamine d-METH, 3,4-methylendioxymethamphetamine (d-MDMA) or d-fenfluramine (d-FEN): neural damage and neural protection.Ann. NY Acad. Sci. 679, 321–324.
Miller D. B. and O’Callaghan J. P. (1994) Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse.J. Pharmacol. Exp. Ther. 270, 752–760.
Miller D. B., Jensen K. F., and O’Callaghan J. P. (1991) Effects of methylenedioxymethamphetamine (MDMA) and fenfluramine (FFA) on motor activity, body temperature and weight— characteristics of acute and repeated dosing.Soc. Neurosci. Abstr. 17, Part 2, 1428.
O’Callaghan J. P. (1991) Quantification of glial fibrillary acidic protein: comparison of slotimmunobinding assays with a novel sandwich ELISA.Neurotoxicol. Teratol. 13, 275–281.
O’Callaghan J. P. (1993) Quantitative features of reactive gliosis following toxicant-induced damage of the CNS.Ann. NY Acad. Sci. 679, 195–210.
O’Callaghan J. P. and Miller D. B. (1993) Quantification of reactive gliosis as an approach to neurotoxicity assessment, inAssessing Neurotoxicity of Drugs of Abuse, National Institute on Drug Abuse Monograph 136 (Erinoff L., ed.), US Government Printing Office, Washington, DC, pp. 188–212.
O’Callaghan J. P. and Miller D. B. (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.J. Pharmacol. Exp. Ther. 270, 741–751.
Pechnick R. N., Wong C. A., George R., Thurkauf J., and Rice K. C. (1989) Comparison of the effects of the acute administration of dexoxadrol, levoxadrol, MK-801 and phencyclidine on body temperature in the rat.Neuropharmacology 28, 829–835.
Ricaurte G., Bryan G., Strauss L., Seiden L., and Schuster C. (1985) Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.Science 229, 986–988.
SAS Institute, Inc. (1986) SAS User’s Guide: Statistics.
Schmidt C. J. (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.J. Pharmacol. Exp. Ther. 240, 1–7.
Severson J. A., Randall P. K., and Finch E. E. (1981) Genotypic influences on striatal dopaminergic regulation in mice.Brain Res. 210, 201–215.
Smith P. K., Kronh R. I., hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimot E. K., Oson B. J., and Klenk D. C. (1985) Measurement of protein using bicinchoninic acid.Anal. Biochem. 150, 76–85.
Sonsalla P. K. and Heikkila R. E. (1988) Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice.Prog. Neuro. Biol. Psychiat. 12, 345–352.
Sonsalla P. K., Nicklas W. J., and Heikkila R. E. (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.Science 243, 398–400.
Stone D. M., Hanson G. R., and Gibb J. W (1987) Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.Neuropharmacology 26, 1657–1661.
Wagner J., Ricaurte G. A., Seiden L. S., Schuster C. R., Miller R. J., and Westely J. (1980) Long-lasting depletion of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine.Brain Res. 181, 151–160.
Widmann R., Miyazawa A., and Hossmann K.-A. (1993) Protective effect of hypothermia on hippocampal injury after 30 minutes of forebrain ischemia in rats is mediated by postischemic recovery of protein synthesis.J. Neurochem. 61, 200–209.
Zheng Y. W. and Laverty R. (1993) Neurotoxic effects of MDMA in different strains of mice.Proc. Univ. Otago Med. Sch. 71, 5,6.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4